Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01661426 · ClinicalTrials.gov registry record · NA

Weight Loss Diet Study: Low Carb vs Low Fat

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
61
Enrollment target

NCT01661426: Completed NA study, sponsored by Stanford University.

NCT01661426 is a NA study that has completed, run by Stanford University. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01661426, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target

Study Summary

The traditional weight loss diet recommended by health professionals has been a low-fat, high-carbohydrate, calorie restricted diet. This recommendation has been challenged by a number of alternative dietary strategies, particularly low-carbohydrate diets. In several recent weight loss studies insulin resistant adults had more success with low- vs. high-carbohydrate diets, in contrast to insulin sensitive adults who had either more success or comparable success with the low-fat diets. The investigators enrolled 61 people with a wide range of insulin sensitivity/resistance. After determining their insulin resistance status, the investigators will split them in the middle and randomly assign them to one of four groups for six months: (1) Low-Carbohydrate/Insulin Resistant (LC/IR); (2) Low-Carbohydrate/Insulin Sensitive (LC/IS); (3) Low-Fat/Insulin Resistant (LF/IR); and (4) Low-Fat/Insulin Sensitive (LF/IS) (15 people/group). After 6 months the participants will switch diet for the following 6 months, i.e. those randomized to the Low-Carbohydrate diet will switch to the Low-Fat diet and vice-versa. The primary outcome of this study is to determine whether weight loss success can be increased if one follows the dietary approach appropriately matched to their insulin resistance status. Secondary outcomes include fasting insulin, glucose, lipids, and fatty acid composition. \--------------------------------------------------------------------------------

Interventions

  • BEHAVIORAL Low-Carbohydrate Diet
  • BEHAVIORAL Low-Fat Diet

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2012-04
Est. Completion 2013-03
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT01661426

The ClinicalTrials.gov registry entry for NCT01661426 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Low-Carbohydrate Diet is the first listed.

NCT01661426 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01661426 about?

NCT01661426 is a clinical study titled "Weight Loss Diet Study: Low Carb vs Low Fat". The traditional weight loss diet recommended by health professionals has been a low-fat, high-carbohydrate, calorie restricted diet. This recommendation has been challenged by a number of alternative dietary strategies, particularly low-carbohydrate diets. In several recent weight loss studies insul...

What is the current status of trial NCT01661426?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2012-04. Estimated completion is 2013-03.

What interventions are being tested in trial NCT01661426?

The interventions under investigation include: Low-Carbohydrate Diet (BEHAVIORAL), Low-Fat Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT01661426?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.